Salarins A and B and tulearin A: New cytotoxic sponge-derived macrolides

Organic Letters

Volumn 10, Issue 2, 2008, Pages 153-156

  Bishara, Ashgan ^a   Rudi, Amira ^a   Aknin, Maurice ^b   Neumann, Drorit ^a   Ben Califa, Nathalie ^a   Kashman, Yoel ^a  

^a TEL AVIV UNIVERSITY   (Israel)

^b UNIVERSITÉ DE LA RÉUNION   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; MACROLIDE; SALARIN A; SALARIN B; UNCLASSIFIED DRUG;

ANIMAL; ARTEMIA; ARTICLE; CHEMICAL STRUCTURE; CHEMISTRY; DRUG EFFECT; DRUG SCREENING; HUMAN; ISOLATION AND PURIFICATION; LARVA; MADAGASCAR; SPONGE (PORIFERA);

ANIMALS; ANTINEOPLASTIC AGENTS; ARTEMIA; DRUG SCREENING ASSAYS, ANTITUMOR; HUMANS; LARVA; MACROLIDES; MADAGASCAR; MOLECULAR STRUCTURE; PORIFERA;

EID: 38749131268     PISSN: 15237060     EISSN: None     Source Type: Journal    
DOI: 10.1021/ol702221v     Document Type: Article

References (22)

1. Kashman, Y.; Rudi, A.; Pappo, D. Pure Appl. Chem. 2007, 79, 491-505.
2. Bishara, A.; Rudi, A.; Goldberg, I.; Benayahu, Y.; Kashman, Y. Tetrahedron 2006, 62, 12092-12097.
3. The identification of the spicule-less sponge genus was not straight-forward. It seems to be closest to Fascaplysinopsis (Demospongiae, order Dictyoceratid, family Thorectidae), a genus described thus far only from Australia and Indonesia.
4. 3N) (10).
5. 4,5 = 15.7 Hz (E).
6. Although transannular NOEs were observed, the high molecule flexibility avoided conclusions regarding the chiral centers of the molecule. More material will have to be gained for attempting derivatization of 1, which thus far has failed to give crystals. All three new compounds are unstable, especially under acidic or basic conditions. In the case of 1 and 2, unstability, most likely, is due to the oxohexa-2,4-dienoate moiety that readily isomerizes.
7. 2C(=NCO-)-] was excluded because of the instability of this group that readily rearranges to the triacyl amine structure. Heard, R. D. H.; Ryan, M. T.; Bolker, H. I. J. Org. Chem. 1959, 24, 172-175.
8. Hassner, A.; Wentworth, W. A.; Pomerantz, I. H.; J. Org. Chem. 1963, 28, 304-306.
9. Iesce, R.; Graziano, M. L.; Cimminiello, G.; Cermola, F.; Parrilli, M.; Scarpati, R. Chem. Soc., Perkin Trans. 2 1991, 1085-1089.
10. 12K 741.2995).
11. Ando, O.; Salake, H.; Nakajima, M.; Sato, A.; Nakamura, T.; Kinoshita, T.; Furuya, K.; Hancishi, T. J. Antibiot. 1991, 44, 382-384.
12. 4).
13. Klein, D.; Braekman, J. C.; Daloze, D.; Hoffmann, L.; Castillo, G.; Demoulin, V. J. Nat Prod. 1999, 62, 934-936.
14. Klein, D.; Braekman, J. C.; Daloze, D.; Hoffmann, L.; Castillo, G.; Demoulin, V. Tetrahedon Lett. 1996, 37, 7519-7520.
15. 6Na 558.3765).
16. Diyabalanage, T.; Amsler, C. D.; McClintok, J. B.; Baker, B. J. J Am. Chem. Soc. 2006, 128, 5630-5631.
17. Neckers, L.; Schulte, T. M.; Mimhaugh, E. Invest. New Drugs 1999, 17, 361-373.
18. Schantz, E. J.; Ghazarossian, V. E.; Schnoes, H. K.; Strong, F. M.; Springer, J. P.; Pezzanite, J. O.; Clardy, J. J. Am. Chem. Soc. 1975, 97, 1238-1239.
19. As with salarins A and B, also for 3, additional material is required for derivatization for configurational studies.
20. Lozzio, C. B. Lozzio, B. B. Blood 1975, 45, 321-323.
21. Komatsu, N.; Nakauchi, H.; Miwa, A.; Ishihara, T.; Eguchi, M.; Moroi, M.; Okada, M.; Sato, Y.; Wada, H.; Yawata, Y.; Suda, T.; Niura, Y. Cancer Res. 1991, 51, 341-348.
22. Mosmann, T. J. Immunol. Meth. 1983, 65, 55-63.